Fetal valproate syndrome in a 14-month-old child: A case report

  • A Abbas
  • U Firdaus

Abstract

Anti-epileptic drugs administered during pregnancy can cause structural defects in the growing fetus and result in adverse neurodevelopmental outcome later in life. Fetal valproate syndrome (FVS) results from teratogenic effects of valproic acid exposure in the prenatal period. It is characterised by a distinctive dysmorphic facies and a cluster of minor and major anomalies, as well as developmental and behavioural abnormalities. We describe a 14-month-old boy with the typical dysmorphic facies and other congenital abnormalities characteristic of FVS. There was a history of maternal intake of sodium valproate during pregnancy. The mechanism of teratogenicity and methods for prevention are discussed.
Published
2013-07-03
Section
Articles

Journal Identifiers


eISSN: 1999-7671
print ISSN: 1994-3032